143 related articles for article (PubMed ID: 38332645)
1. An artificial intelligence algorithm for co-clustering to help in pharmacovigilance before and during the COVID-19 pandemic.
Destere A; Marchello G; Merino D; Othman NB; Gérard AO; Lavrut T; Viard D; Rocher F; Corneli M; Bouveyron C; Drici MD
Br J Clin Pharmacol; 2024 May; 90(5):1258-1267. PubMed ID: 38332645
[TBL] [Abstract][Full Text] [Related]
2. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
[TBL] [Abstract][Full Text] [Related]
3. A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands.
Scholl JHG; van Hunsel FPAM; Hak E; van Puijenbroek EP
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):199-205. PubMed ID: 29271017
[TBL] [Abstract][Full Text] [Related]
4. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.
Chen JJ; Huo XC; Wang SX; Wang F; Zhao Q
Int J Clin Pharm; 2022 Dec; 44(6):1351-1360. PubMed ID: 36178607
[TBL] [Abstract][Full Text] [Related]
5. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence in Pharmacovigilance and COVID-19.
Bhardwaj K; Alam R; Pandeya A; Sharma PK
Curr Drug Saf; 2023; 18(1):5-14. PubMed ID: 35382726
[TBL] [Abstract][Full Text] [Related]
7. Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study.
Yue QX; Ding RF; Chen WH; Wu LY; Liu K; Ji ZL
J Med Internet Res; 2024 May; 26():e48572. PubMed ID: 38700923
[TBL] [Abstract][Full Text] [Related]
8. Portable automatic text classification for adverse drug reaction detection via multi-corpus training.
Sarker A; Gonzalez G
J Biomed Inform; 2015 Feb; 53():196-207. PubMed ID: 25451103
[TBL] [Abstract][Full Text] [Related]
9. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
11. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
Zhou Z; Hultgren KE
JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
[TBL] [Abstract][Full Text] [Related]
12. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
[TBL] [Abstract][Full Text] [Related]
13. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
van Hunsel F; de Waal S; Härmark L
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
[TBL] [Abstract][Full Text] [Related]
14. Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
de Germay S; Singier A; Salvo F; Pariente A;
Drug Saf; 2023 Dec; 46(12):1381-1389. PubMed ID: 37926785
[TBL] [Abstract][Full Text] [Related]
15. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
[TBL] [Abstract][Full Text] [Related]
16. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features.
Nikfarjam A; Sarker A; O'Connor K; Ginn R; Gonzalez G
J Am Med Inform Assoc; 2015 May; 22(3):671-81. PubMed ID: 25755127
[TBL] [Abstract][Full Text] [Related]
17. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.
Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078
[TBL] [Abstract][Full Text] [Related]
18. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
Yang CC; Yang H
Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
[TBL] [Abstract][Full Text] [Related]
19. Filtering big data from social media--Building an early warning system for adverse drug reactions.
Yang M; Kiang M; Shang W
J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
[TBL] [Abstract][Full Text] [Related]
20. Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection.
Plessis L; Gómez A; García N; Cereza G; Figueras A
Eur J Clin Pharmacol; 2017 Jun; 73(6):751-758. PubMed ID: 28251276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]